Omnicell, Inc. (OMCL)
OMCL Stock Price Chart
Explore Omnicell, Inc. interactive price chart. Choose custom timeframes to analyze OMCL price movements and trends.
OMCL Company Profile
Discover essential business fundamentals and corporate details for Omnicell, Inc. (OMCL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
9 Aug 2001
Employees
3.62K
Website
https://www.omnicell.comCEO
Randall A. Lipps
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
OMCL Financial Timeline
Browse a chronological timeline of Omnicell, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 4 Feb 2026
Upcoming earnings on 29 Oct 2025
EPS estimate is $0.36, while revenue estimate is $295.59M.
Earnings released on 31 Jul 2025
EPS came in at $0.45 surpassing the estimated $0.31 by +45.16%, while revenue for the quarter reached $290.56M , missing expectations by -0.53%.
Earnings released on 6 May 2025
EPS came in at $0.26 surpassing the estimated $0.16 by +62.50%, while revenue for the quarter reached $269.67M , missing expectations by -3.04%.
Earnings released on 6 Feb 2025
EPS came in at $0.60 surpassing the estimated $0.57 by +5.26%, while revenue for the quarter reached $306.88M , beating expectations by +3.02%.
Earnings released on 30 Oct 2024
EPS came in at $0.56 surpassing the estimated $0.41 by +36.59%, while revenue for the quarter reached $282.42M , missing expectations by -5.19%.
Earnings released on 1 Aug 2024
EPS came in at $0.51 surpassing the estimated $0.16 by +218.75%, while revenue for the quarter reached $276.79M , beating expectations by +8.46%.
Earnings released on 2 May 2024
EPS came in at $0.03 surpassing the estimated -$0.08 by +137.50%, while revenue for the quarter reached $246.15M , beating expectations by +3.97%.
Earnings released on 8 Feb 2024
EPS came in at $0.33 surpassing the estimated $0.17 by +94.12%, while revenue for the quarter reached $258.85M , beating expectations by +1.29%.
Earnings released on 2 Nov 2023
EPS came in at $0.62 surpassing the estimated $0.45 by +37.78%, while revenue for the quarter reached $298.66M , beating expectations by +1.08%.
Earnings released on 1 Aug 2023
EPS came in at $0.57 surpassing the estimated $0.28 by +103.57%, while revenue for the quarter reached $298.97M , beating expectations by +5.06%.
Earnings released on 2 May 2023
EPS came in at $0.39 surpassing the estimated $0.07 by +457.14%, while revenue for the quarter reached $290.63M , beating expectations by +4.67%.
Earnings released on 28 Feb 2023
EPS came in at $0.33 surpassing the estimated $0.09 by +266.67%, while revenue for the quarter reached $297.67M , beating expectations by +3.66%.
Earnings released on 2 Nov 2022
EPS came in at $1.00 surpassing the estimated $0.94 by +6.38%, while revenue for the quarter reached $348.06M , missing expectations by -4.18%.
Earnings released on 4 Aug 2022
EPS came in at $0.84 falling short of the estimated $0.85 by -1.18%, while revenue for the quarter reached $331.39M , missing expectations by -2.38%.
Earnings released on 28 Apr 2022
EPS came in at $0.83 surpassing the estimated $0.71 by +16.90%, while revenue for the quarter reached $318.83M , beating expectations by +1.42%.
Earnings released on 14 Feb 2022
EPS came in at $0.92 falling short of the estimated $0.95 by -3.16%, while revenue for the quarter reached $311.03M , missing expectations by -0.02%.
Earnings released on 2 Nov 2021
EPS came in at $1.08 surpassing the estimated $0.91 by +18.68%, while revenue for the quarter reached $296.40M , beating expectations by +4.21%.
Earnings released on 29 Jul 2021
EPS came in at $0.97 surpassing the estimated $0.80 by +21.25%, while revenue for the quarter reached $272.74M , meeting expectations.
Earnings released on 29 Apr 2021
EPS came in at $0.83 surpassing the estimated $0.67 by +23.88%, while revenue for the quarter reached $251.84M , beating expectations by +34.69%.
Earnings released on 1 Feb 2021
EPS came in at $0.91 surpassing the estimated $0.86 by +5.81%, while revenue for the quarter reached $249.20M , beating expectations by +15.94%.
Earnings released on 27 Oct 2020
EPS came in at $0.60 surpassing the estimated $0.50 by +20.00%, while revenue for the quarter reached $213.70M , missing expectations by -43.16%.
OMCL Stock Performance
Access detailed OMCL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.